» Articles » PMID: 21710090

Radiographic Evaluation of Furcal Perforations Sealed with Different Materials in Dogs' Teeth

Overview
Journal J Appl Oral Sci
Specialty Dentistry
Date 2011 Jun 29
PMID 21710090
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this work was to evaluate, using radiographic images, the behavior of four materials used to repair root perforations in dogs' teeth.

Material And Methods: Second and third premolars of 6 dogs were used. The 48 teeth were randomly divided into 4 groups (n=12) and the perforations were sealed with one of the following materials: MTA, AH Plus, Vitremer and gutta-percha. Dogs were submitted to general anesthesia, teeth were radiographed and pulp was accessed. Perforations were done, at the maximum curve of the pulp floor, sealed and the accessed coronal cavity was filled with glass ionomer cement (Vidrion R). After 90 days, the dogs were sacrificed and the last x-ray image was taken. Images were analyzed for the presence/absence of periodontal lesions at the perforation region. Data were analyzed statistically by chi-square test at 5% significance level.

Results: There were no statistically significant differences (p>0.05) among AH Plus, Vitremer and gutta-percha groups. MTA produced the smallest number of periodontal lesions (p<0.05).

Conclusions: It may be concluded that none of the tested materials was able to preserve the integrity of the periodontal tissues in the furcation region, and the use of MTA resulted in the least formation of adjacent periodontal bone lesions revealed by the radiographic comparisons.

Citing Articles

Root-filling materials for endodontic surgery: biological and clinical aspects.

Koutroulis A, Kapralos V, Orstavik D, Sunde P Biomater Investig Dent. 2024; 11:42172.

PMID: 39698344 PMC: 11653206. DOI: 10.2340/biid.v11.42172.


Marginal adaptation, solubility and biocompatibility of TheraCal LC compared with MTA-angelus and biodentine as a furcation perforation repair material.

Alazrag M, Abu-Seida A, El-Batouty K, El Ashry S BMC Oral Health. 2020; 20(1):298.

PMID: 33121465 PMC: 7599098. DOI: 10.1186/s12903-020-01289-y.


Periradicular inflammatory response, bone resorption, and cementum repair after sealing of furcation perforation with mineral trioxide aggregate (MTA Angelus™) or Biodentine™.

Reis M, Scarparo R, Steier L, de Figueiredo J Clin Oral Investig. 2019; 23(11):4019-4027.

PMID: 30864115 DOI: 10.1007/s00784-019-02833-z.


Sealing ability of mineral trioxide aggregate Plus™ and Biodentine™ for repair of furcal perforation in primary molars: An study.

Katge F, Shivasharan P, Patil D Contemp Clin Dent. 2016; 7(4):487-492.

PMID: 27994416 PMC: 5141663. DOI: 10.4103/0976-237X.194100.


Repair of an Extensive Furcation Perforation with CEM Cement: A Case Study.

Eghbal M, Fazlyab M, Asgary S Iran Endod J. 2014; 9(1):79-82.

PMID: 24396381 PMC: 3881307.

References
1.
Ford T, Torabinejad M, McKendry D, Hong C, Kariyawasam S . Use of mineral trioxide aggregate for repair of furcal perforations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79(6):756-63. DOI: 10.1016/s1079-2104(05)80313-0. View

2.
Daoudi M, Saunders W . In vitro evaluation of furcal perforation repair using mineral trioxide aggregate or resin modified glass lonomer cement with and without the use of the operating microscope. J Endod. 2002; 28(7):512-5. DOI: 10.1097/00004770-200207000-00006. View

3.
Salman M, Quinn F, Dermody J, Hussey D, Claffey N . Histological evaluation of repair using a bioresorbable membrane beneath a resin-modified glass ionomer after mechanical furcation perforation in dogs' teeth. J Endod. 1999; 25(3):181-6. DOI: 10.1016/S0099-2399(99)80138-1. View

4.
Yildirim T, Gencoglu N, Firat I, Perk C, Guzel O . Histologic study of furcation perforations treated with MTA or Super EBA in dogs' teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100(1):120-4. DOI: 10.1016/j.tripleo.2004.09.017. View

5.
Parirokh M, Torabinejad M . Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action. J Endod. 2010; 36(3):400-13. DOI: 10.1016/j.joen.2009.09.009. View